openPR Logo
Press release

What's driving Digital Genome Market : Eminent Players – Thermo Fisher, Perkin Elmer, Qiagen, Illumina, Becton Dickinson. Agilent, Sigma Aldrich, Fluidigm, Pacific Biosciences, F. Hoffmann-La Roche, Agios, AVEO Oncology and Biomarin, BioReference

03-01-2019 09:19 AM CET | Health & Medicine

Press release from: Global Market Insights, Inc.

Digital Genome Market

Digital Genome Market

U.S. digital genome market size accounted for over 80% of the North American revenue in 2015, mainly due to the presence of established healthcare infrastructure and advanced facilities for effective treatment and care. The successful completion of Human Genome Project (HGP) has attracted significant public and private initiatives, driving the business growth.

In 2015, Germany digital genome market size was valued at over USD 1.4 billion and is anticipated to witness considerable growth till 2024. Increasing investments by public and private companies for development of novel technologies should boost digital genome industry growth.

China digital genome market is set to witness over 10% CAGR owing to favorable government initiative for development of human genetic resources platform and increasing collaboration among research institutes for creation of genomic databases and biobanks.

Request sample copy of this report @ https://www.gminsights.com/request-sample/detail/1219

Some of the players operating in this industry include Perkin Elmer, Qiagen, Illumina, Becton Dickinson, Agilent, Sigma Aldrich, Fluidigm, Pacific Biosciences, Veracyte, Trovagene, Affymetrix and Neogen. The industry participants are investing heavily in R&D to develop innovative products which would provide competitive advantage.

Some of the major players in sequencing and analysis instruments market include Life Technologies, Illumina, Thermo Fisher Scientific, and Roche. Few of the advanced sequencing technologies are Illumina (Solexa) sequencing, Roche 454 sequencing, Ion torrent: proton/ PGM sequencing and SOLiD (sequencing by Oligonucleotide Ligation and Detection) sequencing.

Biotechnology innovation has enabled development of genetically modified organisms (GMOs) in order to introduce specific improvements or traits. Successful production and commercialization of such modified organisms should stimulate business growth. Extensive applications in clinical diagnosis and research will also contribute to industry growth.

Effective disease management strategies for chronic ailments and growing number of private and public investments and grants are forecast to propel digital genome market growth over the forecast years.

Make Inquiry about this report @ https://www.gminsights.com/inquiry-before-buying/1219

Concerns pertaining to security and confidentiality of patient data, lack of experienced professional and complex return on investment structure may hamper the digital genome market growth. Increasing application of digital genomics in next generation sequencing and wide use of microbes in diagnostics industry will stimulate microbiology segment growth; the segment is anticipated to surpass USD 10 billion by 2024.

Bio-pharmaceutical companies accounted for over 45% of digital genome market share due to increasing demand for targeted drug therapy. Growing usage trend for precision medicines should provide lucrative growth opportunities for segment growth.

Digital Genome Market size is set to exceed USD 45 billion by 2024; as per a new research report by Global Market Insights, Inc. Increased adoption of personalized medicine aimed at identifying genomic markers of disease and prescribe drugs that specifically target the pathway will drive the digital genome market size. Growing emphasis on sensitivity and specificity of the gene sequencing instruments should also fuel industry growth.

In 2015, sequencing and analyzing instruments accounted for over 40% of digital genome market share. Technological innovation for development of novel instruments coupled with growing investments in genetic research will provide thrust to industry expansion. Sequencing chips should witness over 10% CAGR owing to continuous R&D in bioinformatics, microfluidics, enzymology, and nanotechnology providing innovative platforms for digital genome market growth.

Report Content

Chapter 1. Methodology and Scope
1.1. Methodology
1.1.1. Initial data exploration
1.1.2. Statistical model & forecast
1.1.3. Industry insights & validation
1.1.4. Scope, definitions & research assumptions
1.2. Data Sources
1.2.1. Primary
1.2.2. Secondary

Chapter 2. Executive Summary
2.1. Digital Genome industry 3600 synopsis, 2012 – 2024 (USD Million)
2.1.1. Business trends
2.1.2. Product trends
2.1.3. Application trends
2.1.4. End-use trends
2.1.5. Regional trends

Chapter 3. Digital Genome Industry Insights
3.1. Industry segmentation
3.2. Industry size and forecast, 2012 – 2024 (USD Million)
3.3. Industry impact forces
3.3.1. Growth drivers
3.3.1.1. Successful completion of the Human Genome Project
3.3.1.2. Increasing public-private investments, funds, and grants
3.3.1.3. Advances in biotechnology
3.3.1.4. Increased Application in clinical diagnosis
3.3.1.5. Rising use of personalized medicine
3.3.1.6. Rise in incidence and prevalence of chronic diseases
3.3.1.7. Reduced cost and high speed for DNA sequencing
3.3.2. Industry pitfalls & challenges
3.3.2.1. Unclear ROI of precision medicine
3.3.2.2. Lack of trained staff
3.4. Growth potential analysis
3.5. Porter's analysis
3.6. Technology landscape
3.6.1. Advent of novel technologies
3.7. Company market share analysis, 2015
3.7.1. Strategy dashboard
3.8. PESTEL analysis

Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.

Arun Hegde
Corporate Sales, USA
Global Market Insights, Inc.
Phone: 1-302-846-7766
Toll Free: 1-888-689-0688
Email: sales@gminsights.com
Blog : http://news-researchers.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release What's driving Digital Genome Market : Eminent Players – Thermo Fisher, Perkin Elmer, Qiagen, Illumina, Becton Dickinson. Agilent, Sigma Aldrich, Fluidigm, Pacific Biosciences, F. Hoffmann-La Roche, Agios, AVEO Oncology and Biomarin, BioReference here

News-ID: 1625893 • Views: 530

More Releases from Global Market Insights, Inc.

Hypochlorite Bleaches Market to hit US$ 300 Mn 2025 | Top Key Players like Adity …
As per the research report by Global Market Insights, Inc., Global Hypochlorite Bleaches Market to cross USD 300 million by 2025 and grow at 3.4% CAGR from 2019 to 2025. It has been projected that the Global hypochlorite bleaches market is expected to reach a consumption of around 485-kilo tons by 2025. Water scarcity as well as rising water costs have led to more emphasis being laid on water recycling and
Feminine Hygiene Products Market: Growing awareness regarding intimate health in …
Global Market Insights, Inc., announces an ongoing comprehensive report on the Feminine Hygiene Products Market. One of the most hushed topics across the world is female hygiene, the negligence of which results in several diseases. Studies claim that nearly 30% to 60 % women across the globe develop urinary tract infection once in their lifetime, mainly due to negligence in proper intimate hygiene. Dearth of knowledge regarding the negative consequences of
Examination Gowns Market 2020 business trends & growth opportunities to 2026
Global Market Insights, Inc., announces an ongoing comprehensive report on the Examination Gowns Market. The exposure to various kinds of hospital acquired infections has led to a spate of health problems for the healthcare professionals as well has the patients. In this regard, experts have been massively shifting to adoption of personal protective equipment or clothing, examination gowns, protecting them from all kinds of infections. These gowns are present in the
Nonwoven Packaging Market to witness increased demand from pharmaceutical sector …
Global Market Insights, Inc., announces an ongoing comprehensive report on the Nonwoven Packaging Market. With the world struggling to fight against negative consequences of industrialization and increased carbon emissions, nonwovens or nonwoven fabrics have emerged as an intrinsic solution for all ecological imbalances across the globe. These fabrics are made from staple fiber and long fibers, merged together by chemical, heat, or mechanical treatment. These are generally used in textile manufacturing

All 5 Releases


More Releases for Genome

Genome Editing Market - Assisting Global Expansion 2025
Global Genome Editing Market: Overview Also known as genome editing with engineered nucleases (GEEN), genome editing is a method of altering DNA within a cell in a safe manner. The technique is also used for removing, adding, or modifying DNA in the genome. By thus editing the genome, it is possible to change the primary characteristic features of an organism or a cell. Request Sample Copy of the Report @ https://www.tmrresearch.com/sample/sample?flag=B&rep_id=2588
Genome Editing Market tremendous demand till 2025
Global Genome Editing Market: Overview Also known as genome editing with engineered nucleases (GEEN), genome editing is a method of altering DNA within a cell in a safe manner. The technique is also used for removing, adding, or modifying DNA in the genome. By thus editing the genome, it is possible to change the primary characteristic features of an organism or a cell. The global genome editing market can be
Genome Editing Market Growth Analysis by 2025
Genome editing is a technique in genetic engineering that involves inserting, deleting or replacing a DNA into the desired locations into a genome of the living organism to change the phenotype of the organism. Genome editing plays a very significant role in modern day biology and is widely used in biotechnology and biopharmaceutical industry to alter the genome of microorganisms to perform process like the fermentation which yield desired products
Genome Engineering Market - Global Industry Analysis 2025
Genome engineering is a process of insertion, deletion, modification or replacement of DNA bases in an organism. Genome engineering has exhibited potential benefits in gene therapy. For instance, various genetic disorders such as Hemophilia, Myotonic dystrophy, Alzheimer’s disease, Sickle cell anemia, Gaucher disease, Cystic fibrosis (involves correction of a single gene) or asthma, autoimmune diseases, cancer, diabetes, and heart disease (involves correction of multiple genes) can be treated using genomic
Genome Engineering Market Analysis & Key Trends 2023
“To develop innovative, technologically advanced and differentiated products, the leading companies are banking on agreements with laboratories and research institutes and pouring funds into ongoing research and development projects,” says the author of the report. The global genome engineering market is anticipated to reach a valuation of US$7.21 bn by 2023 from US$2.30 bn in 2015, expanding at a remarkable CAGR of 14.2% from 2015 to 2023. Increasing Funding by Biotechnology
Genome Editing/Genome Engineering Market Size - Industry Analysis Report 2021
Genome Editing/Genome Engineering Market Size, Capacity, Trends, Outlook, Research, Analysis, Growth | Industry Report 2021 Market Research Report to It’s a Database. Inquire Before Buying @ http://bit.ly/2uh3G7k The genome editing market is projected to reach USD 5.54 billion by 2021 from USD 2.84 billion in 2016, growing at a CAGR of 14.3% in the next five years (2016 to 2021). The genome editing market is undergoing a significant transformation, with the